XML 57 R61.htm IDEA: XBRL DOCUMENT v2.4.0.8
Fair Value Measurement (Tables)
12 Months Ended
Dec. 31, 2013
Fair Value Disclosures [Abstract]  
Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis
  CarryingFair value
  value    
   TotalLevel 1Level 2Level 3
At December 31, 2013 $'M$'M$'M$'M$'M
  _________________________________________________________
Financial assets:      
Available-for-sale securities(1) 6.76.76.7- -
Contingent consideration receivable (2) 36.136.1- - 36.1
Foreign exchange contracts 4.04.0- 4.0-
       
Financial liabilities:      
Foreign exchange contracts 2.82.8- 2.8-
Contingent consideration payable(3) 405.9405.9- - 405.9
  _________________________________________________________
       
   TotalLevel 1Level 2Level 3
At December 31, 2012 $'M$'M$'M$'M$'M
  _________________________________________________________
Financial assets:      
Available-for-sale securities(1) 14.214.214.2- -
Contingent consideration receivable (2) 38.338.3- - 38.3
Foreign exchange contracts 1.31.3- 1.3-
       
Financial liabilities:      
Foreign exchange contracts 3.03.0- 3.0-
Contingent consideration payable(3)1136.4136.4- - 136.4
  _________________________________________________________

(1)       Available-for-sale securities are included within Investments in the consolidated balance sheet.

(2)       Contingent consideration receivable is included within Prepaid expenses and other current assets and Other non-current assets in the consolidated balance sheet.

(3)       Contingent consideration payable is included within Other current liabilities and Other non-current liabilities in the consolidated balance sheet.

 

Assets Measured at Fair Value on a Recurring Basis Using Significant Unobervable Inputs (Level 3)
Contingent consideration receivable  
 20132012
 $'M$'M
 ________________________
   
Balance at January 1,38.337.8
Gain recognized in the income statement (within Gain on sale of product rights) due to change in fair value during the period15.918.1
Reclassification of amounts to Other receivables within Other current assets(19.5)(18.7)
Amounts recorded to other comprehensive income (within foreign currency translation adjustments) 1.41.1
   
Balance at December 31,36.138.3
   
Liabilities Measured at Fair Value on a Recurring Basis Using Significant Unobervable Inputs (Level 3)
Contingent consideration payable  
 20132012
 $'M$'M
 ________________________
   
Balance at January 1,136.4-
Initial recognition of contingent consideration payable451.4127.8
Change in fair value during the period with the corresponding adjustment recognized as a gain in the income statement (within Integration and acquisition costs)(159.1)9.2
Reclassification of amounts to Other current liabilities(13.9)(8.8)
Change in fair value during the period with corresponding adjustment to the associated intangible asset(8.9)8.2
   
Balance at December 31,405.9136.4
   
Fair Value Inputs, Assets Quantitative Information Table
Financial assets:Fair Value at the Measurement Date
    
At December 31, 2013Fair value Valuation Technique Significant unobservable InputsRange
$'M   
_____________________________________________
Contingent consideration receivable ("CCR")36.1Income approach (probability weighted discounted cash flow)• Probability weightings applied to different sales scenarios • Future forecast royalties receivable at relevant contractual royalty rates • Assumed market participant discount rate • 10 to 45% • $40 million to $148 million • 6.2%
 ________________________________________________
     

 Fair Value at the Measurement Date
    
At December 31, 2013Fair value Valuation Technique Significant unobservable InputsRate used
$'M   
_____________________________________________
Movetis-related IPR&D intangible assets20.3Income approach (discounted cash flow)• Decline in forecast peak sales since last impairment test • Assumed market participant discount rate • 50% • 8.9%
     
DERMAGRAFT assets held-for-sale31.6Income approach (discounted cash flow)• Future forecast milestones to be received • Assumed market participant discount rate • $15 -$95 million • 11.5%
 ________________________________________________
Fair Value Inputs, Liabilities Quantitative Information Table
Financial liabilities:Fair Value at the Measurement Date
     
At December 31, 2013Fair value Valuation Technique Significant unobservable InputsRange
$'M   
_____________________________________________
Contingent consideration payable405.9Income approach (probability weighted discounted cash flow)• Cumulative probability of milestones being achieved • Assumed market participant discount rate • Periods in which milestones are expected to be achieved • Forecast quarterly royalties payable on net sales of relevant products • 18 to 57% (Weighted average) • 2.9 to 15% (Weighted average) • 2014 to 2025 • $2.4 to $7.6 million
 ________________________________________________
Schedule of Fair Value, Assets and Liabilities Not Measured at Fair Value on Recurring Basis
  December 31, 2013 December 31, 2012
  Carrying  Carrying 
  amountFair value amountFair value
  $’M$’M $’M$’M
  ________________________ _______________________
       
Financial liabilities:      
Convertible bonds (Level 1) - -  1,100.01,228.2
Building financing obligation (Level 3)  7.810.1 8.010.3
  ________________________ _______________________